CTU Market Analysis

Descriptions

The University of Hertfordshire (UH) is home to the Clinical Trials Support Network (CTSN), which has been operating since 2018 and is now seeking to transition into a fully registered Clinical Trials Unit (CTU) under the UK Clinical Research Collaboration (UKCRC).

The CTSN has developed a strong reputation for supporting complex intervention trials, particularly in non-traditional and non-NHS settings, such as public health and social care. Unlike many CTUs that focus on pharmaceutical or chemical trials, CTSN's niche lies in non-chemical, psychosocial, and behavioural intervention research. However, CTSN also supports Phase IV trials involving investigational medicinal products (CTIMPs), especially those focused on real-world effectiveness and safety. This broader remit allows CTSN to contribute to a wider range of clinical research, including studies that bridge traditional and non-traditional trial methodologies.

To support strategic planning, investment, and positioning of the CTSN as a nationally recognised CTU, UH is commissioning a comprehensive market analysis.

Engagement

Proposals will be evaluated based on: • Demonstrated experience in health research market analysis (please provide 3 case study examples) • Understanding of the UK clinical trials ecosystem • Methodology and approach. Within your response please provide a timeline for how long you envision the project to take. Including your proposed start and end dates. • Value for money. Within your response please include a detailed breakdown of your costs. • Ability to deliver within the required timeframe Please email t.schmidt@herts.ac.uk to express an interest and receive specification documentation.